Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

A comprehensive eight-year study examining audiological outcomes of newborns screened for congenital cytomegalovirus (cCMV) ...

As winter brings a rise in coughs, colds, and fevers, it’s often hard to tell if it’s just a seasonal viral, the flu, or ...

He pretended to be a Dubai resident who wanted to fly back, for which he wanted to undergo the mandatory RT-PCR test. But he ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U ...

Q3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024;Q3 2025 gross profit margin of 81%, a 400-basis point improvement from Q3 ...

Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric ...

By leveraging advanced Polymerase Chain Reaction (PCR) technology with streamlined testing for a broad range of gastrointestinal (GI) bacterial pathogens from a single stool swab sample, the panels ...

A start-up should always have a “plan B” to provide a critical safety net. A considerable and expensive amount of redundant lab equipment can sit idle if that pivot arises and prompts a significant ...

In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...